Update on the use of immunoglobulin in human disease: A review of evidence - Perez, Elena E.; Orange, Jordan S.; Bonilla, Francisco; Chinen, Javier; Chinn, Ivan K.; Dorsey, Morna; El-Gamal, Yehia; Harville, Terry O.; Hossny, Elham; Mazer, Bruce; Nelson, Robert; Secord, Elizabeth; et al. (Journal of allergy and clinical immunology, 2017)
Keywords: adverse events; Allergy and Immunology; Animals; autoimmunity; Evidence-Based Medicine; Humans; IGIV; Immune globulin; immune modulating; Immunity, Humoral; immunoglobulin; Immunoglobulins - therapeutic use; Immunoglobulins, Intravenous - therapeutic use; Immunologic Deficiency Syndromes - immunology; Immunologic Deficiency Syndromes - therapy; Immunomodulation; Injections, Subcutaneous; IVIG; Practice Guidelines as Topic; primary immunodeficiency; SCIG; transfusion; immunomodulation; CLL; FDA; RCT; APS; ITP; SCIG; WAS; transfusion; GVHD; XLA; SCID; SC; immune modulating; CVID; DSA; THI; Immune globulin; primary immunodeficiency; GBS; KD; MG; BMI; MM; SCORAD; AD; JIA; immunoglobulin; MS; IVIG; IGIV; ISR; VOD; adverse events; CIDP; IV; MMN; RA; AT; autoimmunity; RSV; PE; PI; LEMS; PAN; HAART; Transient hypogammaglobulinemia; Multiple sclerosis; Common variable immunodeficiency; Donor-specific HLA antigen; Juvenile idiopathic arthritis; Veno-occlusive disease; Body mass index; Multifocal motor neuropathy; Atopic dermatitis; US Food and Drug Administration; Wiskott-Aldrich syndrome; Subcutaneous; Severity scoring of Alzheimer disease; Randomized controlled trial; Guillain-Barré syndrome; Lambert-Eaton myasthenic syndrome; Rheumatoid arthritis; Ataxia telangiectasia; Highly active antiretroviral treatment; Anti–phospholipid antibody syndrome; Subcutaneous immunoglobulin; Severe combined immunodeficiency; Polyarteritis nodosa; Multiple myeloma; X-linked agammaglobulinemia; Plasma exchange; Kawasaki disease; Myasthenia gravis; Infusion site reaction; Graft-versus-host disease; Intravenous; Intravenous immunoglobulin